Stunning Changes in FDA's Software Regulation

Duration: 60 Minutes
flat 50% off on this webinar
Congress removed some software products out of FDA's jurisdiction. On balance, the benefit did not outweigh the cost of the regulatory burden. That is a stunning "least burdensome approach." FDA is planning to give additional regulatory relief to its regulation of software. Now the question is whether or not you are in a "relief zone." Those boundaries are grey. We are looking at no regulation of some software, easier regulation for some software premarket (510(k)) submissions and an accelerated assessment of products deemed part of a "Digital Health" initiative, which has a startling change for premarket access. Firms can clear their own Software 510(k).
FDA's Software Regulation
Instructor: Casper E Uldriks
Product ID: 503201
Objectives of the Presentation
  • Identify software that is no longer regulated by the FDA
  • Identify FDA guidance documents that will be revised or withdrawn
  • Identify mobile apps exempt from FDA regulation
  • Identify premarket shortcuts for software 510(k) clearance
  • Identify recall reporting options for cybersecurity problems
  • Highlight the FDA's Digital Health initiative
Why Should you Attend
FDA's regulation of software provides major relief to firms involved with software, especially low risk software. Firms should be re-evaluated the software they market to determine if the regulatory relief applies to the software they market. Are you developing your risk assessment? Criteria so you can justify saying, (1) "My software is not regulated" (2) "Does my firm meet the criteria to clear its own software 510(k)'s?" or (3) "My software qualifies as digital health software." These are questions that require work now so that you reap the rewards going forward.

Areas Covered
  • 21st century cure act impact
  • Software no longer under FDA jurisdiction
  • Changes in premarket requirements
  • Voluntary controls short cuts
  • Post market reporting options
  • Digital Health Initiative - FDA clearance not required
Who will Benefit
  • Regulatory affairs directors
  • Software designers / specification developers
  • Production managers
  • Quality assurance directors
  • In-house legal counsel
  • Importers of software-based devices
  • Software engineers
  • information technology managers
  • Third party software services
  • Regulatory Affairs Managers
  • Healthcare institution risk managers
  • Complaint investigation teams
  • Quality assurance directors
Topic Background
FDA has struggled with regulating software for about 25 years. When the Federal Food, Drug, and Cosmetic Act (FDCA) was amended in 1976 to regulate devices, software was not considered. It did not exist as a regulatory issue. With the advent of increasingly sophisticated software, the increasing use of software and the dramatic increase of mobile apps, FDA, the industry, and Congress became aware that FDA was in over its head. Congress has redefined the scope of FDA's jurisdiction over software. In a rare case in history, FDA is scaling back its regulatory boundaries.
$375
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $500.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $600.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Mr. Uldriks held a number of positions at FDA, such as an investigator in FDA's New England office, in the Office of the Commissioner in Legislative Affairs and in the Center for Devices and Radiological Health (CDRH), where he served as CDRH's Associate Director for Regulatory Guidance and Government Affairs. He helped to guide CDRH to develop and implement various medical device related amendments to the Food, Drug, and Cosmetic Act, regulations and guidance documents. For years he has trained FDA staff on medical law and has been a featured speaker at many professional conferences involving FDA's medical device program.
Bar Admissions: Massachusetts, 1986 and District of Columbia, 2011
Education: Suffolk University Law School, Boston, Massachusetts, 1986.
View More